Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT04975334
PHASE1
Opioid Antagonism in Hypogonadotropic Hypogonadism
Sponsor: Stephanie B. Seminara, MD
View on ClinicalTrials.gov
Summary
The goal of this study is to evaluate the effects of opioid antagonists on the hypothalamic-pituitary-gonadal axis in subjects with hypogonadotropic hypogonadism (HH).
Key Details
Gender
MALE
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
23
Start Date
2025-06-18
Completion Date
2025-09-26
Last Updated
2026-05-01
Healthy Volunteers
No
Interventions
DRUG
Naloxone
One bolus of naloxone
Locations (1)
Massachusetts General Hospital
Boston, Massachusetts, United States